BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 26677113)

  • 1. 5-azacytidine inhibits the proliferation of bladder cancer cells via reversal of the aberrant hypermethylation of the hepaCAM gene.
    Wang X; Chen E; Yang X; Wang Y; Quan Z; Wu X; Luo C
    Oncol Rep; 2016 Mar; 35(3):1375-84. PubMed ID: 26677113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of hypermethylation in hepatocyte cell adhesion molecule gene promoter region in bladder carcinoma.
    Tao J; Liu Q; Wu X; Xu X; Zhang Y; Wang Q; Luo C
    Int J Med Sci; 2013; 10(13):1860-7. PubMed ID: 24324362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploration of the correlations between interferon-γ in patient serum and HEPACAM in bladder transitional cell carcinoma, and the interferon-γ mechanism inhibiting BIU-87 proliferation.
    Xu B; He Y; Wu X; Luo C; Liu A; Zhang J
    J Urol; 2012 Oct; 188(4):1346-53. PubMed ID: 22906662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. hepaCAM and p-mTOR closely correlate in bladder transitional cell carcinoma and hepaCAM expression inhibits proliferation via an AMPK/mTOR dependent pathway in human bladder cancer cells.
    Wang Q; Luo C; Wu X; Du H; Song X; Fan Y
    J Urol; 2013 Nov; 190(5):1912-8. PubMed ID: 23669565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNMT1: an emerging target in the treatment of invasive urinary bladder cancer.
    Dhawan D; Ramos-Vara JA; Hahn NM; Waddell J; Olbricht GR; Zheng R; Stewart JC; Knapp DW
    Urol Oncol; 2013 Nov; 31(8):1761-9. PubMed ID: 22609058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Influence of hepatocyte cell adhesion molecule on gene expression profile of human bladder transitional cell carcinoma cell line].
    Wang QJ; Lv CK; Tao J; Du HF; Fan YR; Song XD; Luo CL
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2013 Apr; 35(2):190-8. PubMed ID: 23643009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cigarette smoking extract causes hypermethylation and inactivation of WWOX gene in T-24 human bladder cancer cells.
    Yang W; Cui S; Ma J; Lu Q; Kong C; Liu T; Sun Z
    Neoplasma; 2012; 59(2):216-23. PubMed ID: 22248280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell division is required for de novo methylation of CpG islands in bladder cancer cells.
    Velicescu M; Weisenberger DJ; Gonzales FA; Tsai YC; Nguyen CT; Jones PA
    Cancer Res; 2002 Apr; 62(8):2378-84. PubMed ID: 11956100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional significance of the hepaCAM gene in bladder cancer.
    He Y; Wu X; Luo C; Wang L; Lin J
    BMC Cancer; 2010 Mar; 10():83. PubMed ID: 20205955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alteration of runt-related transcription factor 3 gene expression and biologic behavior of esophageal carcinoma TE-1 cells after 5-azacytidine intervention.
    Wang S; Liu H; Akhtar J; Chen HX; Wang Z
    Asian Pac J Cancer Prev; 2013; 14(9):5427-33. PubMed ID: 24175838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exon 2 methylation inhibits hepaCAM expression in transitional cell carcinoma of the bladder.
    Pan C; Wu X; Luo C; Yang S; Pu J; Wang C; Shen S
    Urol Int; 2010; 85(3):347-54. PubMed ID: 20628239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The SMAD2/3 pathway is involved in hepaCAM-induced apoptosis by inhibiting the nuclear translocation of SMAD2/3 in bladder cancer cells.
    Wang X; Chen E; Tang M; Yang X; Wang Y; Quan Z; Wu X; Luo C
    Tumour Biol; 2016 Aug; 37(8):10731-43. PubMed ID: 26873485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of 5-azacytidine on RUNX3 gene expression and the biological behavior of esophageal carcinoma cells.
    Wang S; Liu H; Wang Z; Chen HX
    Mol Med Rep; 2014 Apr; 9(4):1259-65. PubMed ID: 24535051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decrease of DNA methyltransferase 1 expression relative to cell proliferation in transitional cell carcinoma.
    Kimura F; Seifert HH; Florl AR; Santourlidis S; Steinhoff C; Swiatkowski S; Mahotka C; Gerharz CD; Schulz WA
    Int J Cancer; 2003 May; 104(5):568-78. PubMed ID: 12594811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin 6 induces cell proliferation of clear cell renal cell carcinoma by suppressing hepaCAM via the STAT3-dependent up-regulation of DNMT1 or DNMT3b.
    Quan Z; He Y; Luo C; Xia Y; Zhao Y; Liu N; Wu X
    Cell Signal; 2017 Apr; 32():48-58. PubMed ID: 28093267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of Med19 in bladder cancer tissues and its role on bladder cancer cell growth.
    Zhang H; Jiang H; Wang W; Gong J; Zhang L; Chen Z; Ding Q
    Urol Oncol; 2012; 30(6):920-7. PubMed ID: 21478038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic inactivation of Wnt inhibitory factor-1 plays an important role in bladder cancer through aberrant canonical Wnt/beta-catenin signaling pathway.
    Urakami S; Shiina H; Enokida H; Kawakami T; Tokizane T; Ogishima T; Tanaka Y; Li LC; Ribeiro-Filho LA; Terashima M; Kikuno N; Adachi H; Yoneda T; Kishi H; Shigeno K; Konety BR; Igawa M; Dahiya R
    Clin Cancer Res; 2006 Jan; 12(2):383-91. PubMed ID: 16428476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of estrogen receptors-alpha and -beta in bladder cancer cell lines and human bladder tumor tissue.
    Shen SS; Smith CL; Hsieh JT; Yu J; Kim IY; Jian W; Sonpavde G; Ayala GE; Younes M; Lerner SP
    Cancer; 2006 Jun; 106(12):2610-6. PubMed ID: 16700038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic silencing of the dual-role signal mediator, ANGPTL4 in tumor tissues and its overexpression in the urothelial carcinoma microenvironment.
    Hsieh HY; Jou YC; Tung CL; Tsai YS; Wang YH; Chi CL; Lin RI; Hung SK; Chuang YM; Wu SF; Li C; Shen CH; Chan MWY; Hsu CD
    Oncogene; 2018 Feb; 37(5):673-686. PubMed ID: 29035390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of HepaCAM inhibits bladder cancer cell proliferation and viability through the AKT/FoxO pathway.
    Tang M; Zhao Y; Liu N; Chen E; Quan Z; Wu X; Luo C
    J Cancer Res Clin Oncol; 2017 May; 143(5):793-805. PubMed ID: 28229220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.